|
Public |
|
| Healthcare & Pharmaceuticals - Biotechnology | |
| over $1B | |
| over 10K | |
| www.criver.com | |
| (781) 222-6000 | |
| (978) 988-5665 | |
Charles River Laboratories International, Inc. (Charles River) is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company operates in two segments: Research Models and Services (RMS) and Preclinical Services (PCS). Through its RMS segment, it is supplying research models to the drug development industry. It is engaged in the production and sale of rodent research model strains, genetically and microbiologically defined purpose-bred rats and mice. Services provided by its PCS business segment enable its clients to outsource their regulatory-required safety assessment and relat... (Source: SEC reports)
Competitor - 1/10
Which company is more competitive with Charles River Laboratories Intl?
Aug 8, 2018 17:30:53
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today
reported its results for the second [...]
Jul 11, 2018 19:12:26
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release
second-quarter 2018 financial results on [...]
Jul 11, 2018 17:30:49
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release
second-quarter 2018 financial results on [...]
Jun 4, 2018 18:54:21
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at the Jefferies 2018 Global Healthcare
[...]
Jun 4, 2018 17:30:42
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at the Jefferies 2018 Global Healthcare
[...]